Opaleye Management Inc. - May 25, 2021 Form 4 Insider Report for Eton Pharmaceuticals, Inc. (ETON)

Role
10%+ Owner
Signature
Opaleye Management Inc., By: /s/ James Silverman, President
Stock symbol
ETON
Transactions as of
May 25, 2021
Transactions value $
-$2,064,511
Form type
4
Date filed
5/27/2021, 07:34 PM
Next filing
Jun 17, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ETON Common Stock, par value $0.001 per share Sale -$392K -46K -1.18% $8.53 3.84M May 25, 2021 By Opaleye, L.P. F1
transaction ETON Common Stock, par value $0.001 per share Sale -$17.1K -2K -1.29% $8.53 153K May 25, 2021 By Managed Account F2
transaction ETON Common Stock, par value $0.001 per share Sale -$561K -65.5K -1.71% $8.57 3.77M May 26, 2021 By Opaleye, L.P. F1
transaction ETON Common Stock, par value $0.001 per share Sale -$24K -2.8K -1.83% $8.57 150K May 26, 2021 By Managed Account F2
transaction ETON Common Stock, par value $0.001 per share Sale -$1.03M -121K -3.22% $8.49 3.65M May 27, 2021 By Opaleye, L.P. F1
transaction ETON Common Stock, par value $0.001 per share Sale -$39.1K -4.6K -3.06% $8.49 146K May 27, 2021 By Managed Account F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund.
F2 Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Managed Account.